Annual check-ups save lives by detecting prostate issues early, yet many men avoid these crucial tests due to fear or misconceptions. Prostate health ...

After skin cancer, prostate cancer is the most common cancer in men in the US. A new treatment is giving men more options.

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Kearney Urology Center has reported a 50% reduction in biopsies since adopting EpiSwitch® PSE, a new accurate blood test for prostate cancer. The reduction is down to the marked improvement offered by ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Discover the study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC.

Overall, PSMA-PET/CT detected distant metastasis in 84 of 182 cases (46%) that were negative by other types of imaging, ...

A novel polygenic risk score (PRS) may be useful for identifying men on active surveillance (AS) for prostate cancer who are ...

First, a high level of PSA screening occurred in the control ... cancer mortality might be the result of better-than-expected treatment for prostate cancer (80–90% of diagnosed men underwent ...

After skin cancer, prostate cancer is the most common cancer in men in the US. For the men who have beat prostate cancer once, 20 to 30 percent will show signs of recurrence after the five-year mark ...

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...

The following is a summary of “Elevated Fcy receptor expression augments pro-inflammatory macrophage phagocytosis in systemic ...